Cancer prevention and Research Institute of Texas Awards 36.7 million $, UT Southwestern agent for cancer studies

More than $36.7 million in new grants to support to recruit investigators at UT Southwestern Medical Center, cancer in projects to promote connection and outstanding cancer investigators received the cancer prevention and Research Institute of Texas (CPRIT). CPRIT was created in 2007 to Texas voters a constitutional amendment that cancer programs authorized the State to finance research and prevention.

The most financing led UT Southwestern received these awards, made according to a rigorous peer-review process, the last round of grants of each individual institution of Texas in CPRIT. Awards for UT Southwestern researchers were part of the $116 million for 22 projects on 16 Texas-based academic institutions and private companies award. This round of grants is part of the Institute this year be expected of $ 216 million.

Announced March 24 more than $30 million to support projects, involving 20 outstanding researchers include financing of UT Southwestern. These include new imaging technology and techniques for the identification and tracking types of cancer. Repair damaged DNA strands; the development of new drugs and drug-delivery systems; and with a Texas cancer cell repository for the storage of cancer cells and tumors for future study. The awards are also $6 million to recruit outstanding researchers.

"CPRIT funds provide a powerful engine, the best and brightest minds of UT Southwestern and Texas, to win", said Dr. Daniel k. Podolsky, President of UT Southwestern. "These awards are research on cancer care speed up dramatically the effects of the UT Southwestern and illustrate the importance of the team of doctors and researchers work together, defeat to cancer."

Dr. James Willson, Director of the Harold C. Simmons Comprehensive Cancer Center at UT Southwestern, said, "giving numerous awards investigated the molecular mechanisms of cancer on the development of novel therapies and ways to detect cancer." "The projects funded select the forefront basic science and laboratory to translate knowledge into practical applications and technologies."

The grants, the investigators at UT Southwestern are:

-$ 10,996,946 DRS. Steven McKnight, Bruce Posner, Noelle Williams, John Minna, Michael White and Joseph ready to install cancer medicines by identifying objectives develop and lead compounds for the treatment of non-small cell lung cancer (NSCLC after failure) of joining techniques chemical, biological, genetic, and computer science disciplines.

-$ 4,569,454 DRS. Elizabeth Ward Ober, Ralph Mason and Philip Thorpe to the development of a new class of Therapeutics for the treatment of cancer, the brain and nervous system, breast, liver, interhepatic bile duct, lung, Bronchs, and prostate.

-$ 4,200,000 Dr. Xiankai Sun, to develop the specific biological or metabolic pathways of cancer a new kind of novel radio-tracers cyclotron enables to develop better Positron Emission Tomography (PET) imaging inspection point.

-$ 3,291,783 on David DRS. Chen and Hong Tao Yu diagnostic events to identify where a choice of ways to the repair of DNA, the most important unresolved issues in are to carry out such as its repair.

-$ 3,540,725 DRS. Hak CHOY, Chul Ahn to improve Robert Timmerman and Timothy Solberg and create new technologies for radiation therapy for lung cancer and at the same time the toxicity. It includes clinical studies to evaluate the current technologies, new technologies to keep track of tumors and the effectiveness of treatments and improvement of imaging techniques.

-$ 3,390,840 DRS. Jay Schneider, Eric Olsen and Joseph Hill to discover how chemotherapy hurt the heart, including regulatory molecules, that to damage lead, heart muscle cells; such as chemotherapy, stem cells and blood vessel cells in the heart damage; and development of new therapies to prevent, alleviate or reverse cardiac damage.

-$ 750,514, Dr. Adi Gazdar makes Texas cancer cell repository, to develop and home grown in test tubes and human tumors in mice with a focus on grown ovarian and lung cancers proved.

-$ 6 Million dollars for the setting of the three new members of staff.

Source: UT Southwestern Medical Center